Global Wound Debridement Products Strategic Business Report 2019: Annual Estimates & Forecasts 2016-2024 - Honey as a Debridement Agent Gains Prominence
DUBLIN, Feb. 13, 2019 /PRNewswire/ --
The "Wound Debridement Products - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Wound Debridement Products in US$ Thousand.
The report profiles 29 companies including many key and niche players such as:
- Advanced Medical Solutions Group plc (UK)
- Coloplast A/S (Denmark)
- DeRoyal Industries, Inc.
- Derma Sciences, Inc. (USA)
- Lohmann & Rauscher GmbH (Germany)
- Misonix, Inc. (USA)
- MediWound Ltd. (Israel)
- Medline Industries, Inc. (USA)
- Smith & Nephew Plc (UK)
- Soering GmbH (Germany)
- Welcare Industries SpA (Italy)
- Zimmer Biomet Holdings, Inc. (USA)
Key Topics Covered:
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
2. INDUSTRY OVERVIEW
Wound Debridement - Market Overview
Various Debridement Methods Available
Current and Future Analysis
Competition
Leading Players in the Global Wound Debridement Products Market by Segment
Chronic Wounds and Healthcare Burden
Chronic Wounds Statistics
Prevalence of Wounds - Select Statistics
Growing Incidence of Hard-to-Heal Wounds, and Increased Wound Care Costs Drive Debridement Products Market
Diabetic Foot Ulcers - An Critical Area for Wound Debridement Products
Rise in Prevalence of Pressure Ulcers and the Growing Focus on Treatment Solutions
Maintenance Debridement Sustains Adoption of Debridement Products/Techniques
3. MARKET TRENDS AND DRIVERS
Santyl - The Leading Enzymatic Debridement Agent
Monofilament Polyester Fibre Pads Buoy Growth in Mechanical Debridement Market
Hydrosurgery Emerges as a Safe and Cost Effective Method
Micro Water Jet Technology (MWT) - Highly Efficient Means of Debridement
Robotic MWT
Ultrasound Emerges as a Viable Option to Promote Improved Wound Healing
SonicOne for Ultrasonic Debridement
Honey as a Debridement Agent Gains Prominence
Larvae Therapy Re-Emerges as an Effective Debridement Technology
Plasma-Mediated Bipolar Radio Frequency Ablation Demonstrates Selective Ablation
CPI Wound Therapy System Enables Bedside Pressurized Irrigation
Jetox Lavage Systems
4. MACRO GROWTH DRIVERS
Expanding Aging Population Spurs Demand
Hospital Acquired Infections Boost Demand
5. PRODUCT OVERVIEW
Debridement
Purpose of Debridement
Factors Influencing Debridement Decision
Methods/Techniques of Debridement
Autolytic Debridement
Biologic Debridement
Chemical/Enzymatic Debridement
Mechanical Debridement
Surgical Debridement
Ultrasound
Types of Wounds
Acute Wounds
Surgical Incisions
Burns
Chemical Burns
Electrical Burns
Flash Burns
Radiation Burns
Thermal Burns
Chronic Wounds
Diabetic Ulcers
Venous Ulcers
Pressure Ulcers
Process of Wound Care
Preparation
Controlling Bleeding
Irrigation and Cleaning
Closure
Infection Control
Wound Healing Process
Injury
Inflammatory Response
Characteristics
Coagulation Cascade
Vasodilation
Cellular Activity
Debridement, Cell Growth and Healing
Scarring
Abnormal Scarring
Fetal Wound Healing
6. COMPETITIVE LANDSCAPE
6.1 Focus on Select Global Players
6.2 Recent Industry Activity
MediWound Receives Additional Award Contract from BARDA to Develop NexoBrid for Sulfur Mustard Injuries
MediWound Receives Marketing Authorization for NexoBrid in Russia
MediWound Announces the Expansion of NexoBrid Phase 3 Children Innovation Debridement Study (CIDS) to the U.S.
MediWound Completes Enrollment of NexoBrid's Phase 3 DETECT Study in U.S.
MediWound Receives Marketing Authorization for NexoBrid in South Korea
B. Braun Introduces 1-Ounce Prontosan Wound Gel X
MediWound Signs New Distribution Agreement with Holy Stone Healthcare
MediWound Completes U.S. Phase 3 DETECT Study Enrollment for NexoBrid
MediWound Completes Second Cohort of EscharEx Phase 2 Study
MPP Group Introduces Dextranomer-Based Advanced Wound Care Products
Integra LifeSciences Acquires Derma Sciences Inc.
Lohmann & Rauscher Introduces Debrisoft Lolly
Misonix Introduces SonicVac based on LFDCU Debridement Technology
Topigenix Launches Topigenix Wound Care Line
EscharEx from MediWound Completes Phase II Clinical Trial
7. GLOBAL MARKET PERSPECTIVE
8. REGIONAL MARKET PERSPECTIVE
8.1 The United States
Ageing Demographics and Rising Chronic Disease Incidence Drive Market Growth
High Prevalence of Diabetes Drive Growth in Debridement Procedures
Rising Incidence of Pressure Ulcers Drives Demand for Wound Debridement Products
Alarming Rise in Obesity to Drive Demand
Medicare Reimbursement
National Medicare Reimbursement Rates
8.2 Canada
Rising Wound Incidence in Canada - A Key Growth Driver
Diabetes Statistics in Canada: An Opportunity Indicator
8.3 Japan
Aging Population to Drive Opportunities
Rising Incidence of Chronic Diseases - A Key Growth Driver
8.4 Europe
High Wound Prevalence - A Strong Growth Driver
Diabetes Statistics in Europe
8.5 Asia-Pacific
Rise in Incidence of Diabetes Mellitus Drives Market Growth
8.6 Latin America
Diabetes Statistics in Latin America
8.7 Rest of World
Rise in Incidence of Chronic Conditions Offers Positive Growth Prospects
Diabetes Statistics Africa
Key Opportunity Indicator: Aging Population
9. COMPANY PROFILES
Total Companies Profiled: 29 (including Divisions/Subsidiaries - 36)
- The United States (24)
- Canada (1)
- Europe (9)
- Germany (4)
- The United Kingdom (3)
- Italy (1)
- Rest of Europe (1)
- Asia-Pacific (Excluding Japan) (1)
- Middle East (1)
For more information about this report visit https://www.researchandmarkets.com/research/qzm676/global_wound?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article